James Edgemond insider trades: UNITED THERAPEUTICS (UTHR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
45 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | UTHR | ↓ Sell | 8,750 | $538.15 | $4.7M | Direct | Jun 23, 2026 (1d) |
| Jun 18, 2026 | UTHR | ↓ Sell | 10,000 | $540.15 | $5.4M | Direct | Jun 22, 2026 (4d) |
| Jun 15, 2026 | UTHR | ↓ Sell | 10,000 | $549.17 | $5.5M | Direct | Jun 16, 2026 (1d) |
| Jun 11, 2026 | UTHR | ↓ Sell | 10,000 | $549.29 | $5.5M | Direct | Jun 12, 2026 (1d) |
| Jun 8, 2026 | UTHR | ↓ Sell | 10,000 | $547.50 | $5.5M | Direct | Jun 9, 2026 (1d) |
| Jun 1, 2026 | UTHR | ↓ Sell | 10,000 | $547.87 | $5.5M | Direct | Jun 2, 2026 (1d) |
| May 28, 2026 | UTHR | ↓ Sell | 10,000 | $565.63 | $5.7M | Direct | May 29, 2026 (1d) |
| May 26, 2026 | UTHR | ↓ Sell | 10,000 | $572.94 | $5.7M | Direct | May 27, 2026 (1d) |
| May 21, 2026 | UTHR | ↓ Sell | 10,000 | $564.11 | $5.6M | Direct | May 22, 2026 (1d) |
| May 18, 2026 | UTHR | ↓ Sell | 10,000 | $567.31 | $5.7M | Direct | May 19, 2026 (1d) |
| May 14, 2026 | UTHR | ↓ Sell | 10,000 | $574.47 | $5.7M | Direct | May 15, 2026 (1d) |
| May 11, 2026 | UTHR | ↓ Sell | 10,000 | $573.03 | $5.7M | Direct | May 12, 2026 (1d) |
| May 7, 2026 | UTHR | ↓ Sell | 10,000 | $578.58 | $5.8M | Direct | May 11, 2026 (4d) |
| May 4, 2026 | UTHR | ↓ Sell | 10,000 | $576.93 | $5.8M | Direct | May 5, 2026 (1d) |
| Apr 27, 2026 | UTHR | ↓ Sell | 10,000 | $568.83 | $5.7M | Direct | Apr 28, 2026 (1d) |
| Apr 20, 2026 | UTHR | ↓ Sell | 10,000 | $577.86 | $5.8M | Direct | Apr 21, 2026 (1d) |
| Apr 16, 2026 | UTHR | ↓ Sell | 10,000 | $577.18 | $5.8M | Direct | Apr 17, 2026 (1d) |
| Apr 13, 2026 | UTHR | ↓ Sell | 10,000 | $574.88 | $5.7M | Direct | Apr 14, 2026 (1d) |
| Apr 9, 2026 | UTHR | ↓ Sell | 10,000 | $577.89 | $5.8M | Direct | Apr 10, 2026 (1d) |
| Apr 6, 2026 | UTHR | ↓ Sell | 10,000 | $558.40 | $5.6M | Direct | Apr 7, 2026 (1d) |
| Apr 2, 2026 | UTHR | ↓ Sell | 10,000 | $561.50 | $5.6M | Direct | Apr 6, 2026 (4d) |
| Mar 30, 2026 | UTHR | ↓ Sell | 10,000 | $593.17 | $5.9M | Direct | Mar 31, 2026 (1d) |
| Mar 23, 2026 | UTHR | ↓ Sell | 10,000 | $527.48 | $5.3M | Direct | Mar 24, 2026 (1d) |
| Dec 15, 2025 | UTHR | ↓ Sell | 3,517 | $495.36 | $1.7M | Direct | Dec 16, 2025 (1d) |
| Dec 8, 2025 | UTHR | ↓ Sell | 21,000 | $478.60 | $10.1M | Direct | Dec 9, 2025 (1d) |
| Dec 1, 2025 | UTHR | ↓ Sell | 21,000 | $479.99 | $10.1M | Direct | Dec 2, 2025 (1d) |
| Nov 24, 2025 | UTHR | ↓ Sell | 21,000 | $473.64 | $9.9M | Direct | Nov 26, 2025 (2d) |
| Nov 17, 2025 | UTHR | ↓ Sell | 21,000 | $470.36 | $9.9M | Direct | Nov 18, 2025 (1d) |
| Nov 10, 2025 | UTHR | ↓ Sell | 21,000 | $452.07 | $9.5M | Direct | Nov 12, 2025 (2d) |
| Nov 4, 2025 | UTHR | ↓ Sell | 21,000 | $436.09 | $9.2M | Direct | Nov 5, 2025 (1d) |
| Jun 9, 2025 | UTHR | ↓ Sell | 12,000 | $325.37 | $3.9M | Direct | Jun 10, 2025 (1d) |
| Jun 2, 2025 | UTHR | ↓ Sell | 12,000 | $325.82 | $3.9M | Direct | Jun 3, 2025 (1d) |
| Nov 4, 2024 | UTHR | ↓ Sell | 7,778 | $374.02 | $2.9M | Direct | Nov 5, 2024 (1d) |
| Oct 28, 2024 | UTHR | ↓ Sell | 7,800 | $350.00 | $2.7M | Direct | Oct 29, 2024 (1d) |
| Oct 21, 2024 | UTHR | ↓ Sell | 7,782 | $366.99 | $2.9M | Direct | Oct 22, 2024 (1d) |
| Oct 14, 2024 | UTHR | ↓ Sell | 7,792 | $355.88 | $2.8M | Direct | Oct 15, 2024 (1d) |
| Oct 7, 2024 | UTHR | ↓ Sell | 7,794 | $355.54 | $2.8M | Direct | Oct 8, 2024 (1d) |
| Sep 30, 2024 | UTHR | ↓ Sell | 7,792 | $358.62 | $2.8M | Direct | Oct 1, 2024 (1d) |
| Sep 23, 2024 | UTHR | ↓ Sell | 7,796 | $354.04 | $2.8M | Direct | Sep 24, 2024 (1d) |
| Sep 16, 2024 | UTHR | ↓ Sell | 7,810 | $339.12 | $2.6M | Direct | Sep 17, 2024 (1d) |
| Sep 9, 2024 | UTHR | ↓ Sell | 7,802 | $345.41 | $2.7M | Direct | Sep 10, 2024 (1d) |
| Sep 3, 2024 | UTHR | ↓ Sell | 7,785 | $362.37 | $2.8M | Direct | Sep 4, 2024 (1d) |
| Aug 26, 2024 | UTHR | ↓ Sell | 7,799 | $347.60 | $2.7M | Direct | Aug 26, 2024 (0d) |
| Aug 19, 2024 | UTHR | ↓ Sell | 7,828 | $329.02 | $2.6M | Direct | Aug 20, 2024 (1d) |
| May 15, 2024 | UTHR | ↓ Sell | 40,160 | $272.69 | $11.0M | Direct | May 16, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other UTHR insiders
Open-market trades in the last 12 months
About James Edgemond's insider trades
James Edgemond is CFO and Treasurer at UNITED THERAPEUTICS (UTHR). Since May 15, 2024, James has reported no open-market purchases and 45 sales worth $241.1M on SEC Form 4. In the last 12 months: 29 sales ($180.1M).
Their filings also include option exercises (47 filings), grants and awards (9 filings), shares withheld for taxes (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTHR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.